X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2763) 2763
Book Review (161) 161
Publication (68) 68
Dissertation (21) 21
Conference Proceeding (17) 17
Book Chapter (7) 7
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1688) 1688
animals (934) 934
ginsenosides (905) 905
ginsenosides - pharmacology (658) 658
pharmacology & pharmacy (593) 593
rats (568) 568
ginseng (558) 558
male (535) 535
ginsenoside rg1 (516) 516
mice (481) 481
humans (479) 479
panax - chemistry (456) 456
saponins (422) 422
ginsenoside (399) 399
chemistry, medicinal (388) 388
panax-ginseng (379) 379
apoptosis (341) 341
panax ginseng (326) 326
integrative & complementary medicine (274) 274
ginsenosides - chemistry (269) 269
rats, sprague-dawley (252) 252
analysis (250) 250
cells (249) 249
oxidative stress (237) 237
biochemistry & molecular biology (223) 223
plant sciences (217) 217
expression (213) 213
chemistry, analytical (209) 209
in-vitro (201) 201
female (187) 187
activation (181) 181
research article (168) 168
food science & technology (157) 157
ginsenosides - analysis (153) 153
rg1 (150) 150
ginsenosides - therapeutic use (149) 149
mass spectrometry (149) 149
cells, cultured (146) 146
ginsenoside rb1 (146) 146
neurosciences (146) 146
chromatography, high pressure liquid (144) 144
inflammation (144) 144
cell biology (143) 143
dose-response relationship, drug (142) 142
pharmacology (141) 141
metabolites (140) 140
saponins - pharmacology (139) 139
american ginseng (137) 137
ginsenosides - administration & dosage (137) 137
apoptosis - drug effects (135) 135
research (135) 135
ginsenosides - metabolism (132) 132
inhibition (130) 130
brain (129) 129
metabolism (128) 128
panax (128) 128
chemistry, multidisciplinary (125) 125
plant extracts - pharmacology (124) 124
biochemical research methods (123) 123
gene expression (123) 123
ginsenosides - isolation & purification (123) 123
health aspects (119) 119
biotechnology & applied microbiology (117) 117
medicine, research & experimental (117) 117
pharmacokinetics (117) 117
rodents (117) 117
cell line (116) 116
proteins (116) 116
chemistry (114) 114
cancer (113) 113
chromatography, high pressure liquid - methods (111) 111
liquid chromatography (110) 110
panax notoginseng (110) 110
plant roots - chemistry (110) 110
red ginseng (109) 109
signal transduction - drug effects (109) 109
drugs, chinese herbal - pharmacology (107) 107
mice, inbred c57bl (106) 106
botany (105) 105
disease models, animal (105) 105
physiological aspects (104) 104
performance liquid-chromatography (103) 103
panax-notoginseng (102) 102
biotransformation (101) 101
cell proliferation - drug effects (101) 101
herbal medicine (100) 100
rb1 (100) 100
roots (100) 100
medicine, botanic (98) 98
medicine, herbal (98) 98
cell survival - drug effects (97) 97
ginsenosides - pharmacokinetics (97) 97
neuroprotective agents - pharmacology (97) 97
phytotherapy (96) 96
care and treatment (95) 95
compound k (95) 95
ischemia (95) 95
biotechnology (94) 94
proliferation (93) 93
cell line, tumor (92) 92
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 02/2016, Volume 101, pp. 480 - 489
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 2015, Volume 5, Issue 1, pp. 7790 - 7790
Journal Article
Toxicology Letters, ISSN 0378-4274, 01/2016, Volume 243, pp. 7 - 21
Journal Article
Acta Pharmaceutica Sinica B, ISSN 2211-3835, 10/2016, Volume 6, Issue 6, pp. 593 - 599
Ginsenoside Rg1 (Rg1), the major effective component of ginseng, has been shown to have multiple bioactivities, but low oral bioavailability. The aim of this... 
Ginsenoside Rg1 | Excretion | Protopanaxatriol | Ginsenoside Rh1 | LC–MS/MS | ACTIVE SAPONINS | LC-MS/MS | RB-1 | PLASMA | PHARMACOKINETICS | PANAX-NOTOGINSENG | IMPROVEMENT | TRADITIONAL CHINESE MEDICINE | PHARMACOLOGY & PHARMACY | ABSORPTION | Original | LC–MS
Journal Article
INTERNATIONAL JOURNAL OF NANOMEDICINE, ISSN 1178-2013, 2017, Volume 12, pp. 6477 - 6486
Diabetic cerebral infarction is with poorer prognosis and high rates of mortality. Ginsenoside Rg1 (Rg1) has a wide variety of therapeutic values for central... 
blood-brain barrier | MIGRATION | poly-gamma-glutamic acid | ARTERY OCCLUSION | QUANTIFICATION | OX26 | NANOSCIENCE & NANOTECHNOLOGY | PROVIDES NEUROPROTECTION | DELIVERY | ENDOTHELIAL PROGENITOR CELLS | IN-VITRO | VASCULAR COMPLICATIONS | ginsenoside Rg1 | PHARMACOLOGY & PHARMACY | DYSFUNCTION | TRIPTOLIDE | Cerebral Infarction - drug therapy | Diabetes Mellitus, Experimental - drug therapy | Nanoparticles - chemistry | Male | Polyglutamic Acid - analogs & derivatives | Cerebral Infarction - physiopathology | Neuroprotective Agents - pharmacokinetics | Ginsenosides - administration & dosage | Diabetes Mellitus, Experimental - complications | Neuroprotective Agents - administration & dosage | Antibodies, Monoclonal - chemistry | Antibodies, Monoclonal - immunology | Brain - physiopathology | Blood-Brain Barrier - drug effects | Rats, Sprague-Dawley | Brain - drug effects | Particle Size | Polyglutamic Acid - chemistry | Animals | Receptors, Transferrin - immunology | Cerebral Infarction - etiology | Drug Liberation | Nanoparticles - administration & dosage | Drug Delivery Systems - methods | Dynamic Light Scattering | Ginsenosides - pharmacokinetics | Nanoparticles | Drug delivery systems | Diabetes | Ischemia | Hemodialysis | Molecular weight | Index Medicus | blood brain barrier | transferrin receptor | Diabetic cerebral infarction | Ginsenoside Rg1 nanoparticle
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2012, Volume 166, Issue 6, pp. 1872 - 1887
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 09/2015, Volume 762, pp. 333 - 343
Journal Article
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 09/2012, Volume 63, Issue 3, pp. 349 - 361
Ginsenoside Rg1 (Rg1) acts as a neuroprotective agent against various insults, however, the underlying mechanism has not been fully elucidated yet. Here, we... 
β-Amyloid | Ginsenoside Rg1 | ERK1/2 phosphorylation | Receptor nuclear translocation | Protein tyrosine nitration | ACTIVATION | NITRIC-OXIDE SYNTHASE | ALZHEIMERS-DISEASE | KINASE | ISCHEMIA | NEUROSCIENCES | SIGNALING PATHWAY | ENDOTHELIAL-CELLS | beta-Amyloid | PHARMACOLOGY & PHARMACY | NF-KAPPA-B | EXPRESSION | PARKINSONS-DISEASE | Immunohistochemistry | Neuroprotective Agents | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | NF-kappa B - metabolism | Ginsenosides - pharmacology | Cerebral Cortex - cytology | Cerebral Cortex - metabolism | Female | Cerebral Cortex - drug effects | Neurons - drug effects | Receptors, Glucocorticoid - drug effects | Real-Time Polymerase Chain Reaction | Cell Survival - drug effects | Amyloid beta-Peptides - toxicity | Reactive Nitrogen Species - metabolism | Cells, Cultured | Rats | Rats, Sprague-Dawley | Blotting, Western | Estrogen Receptor alpha - drug effects | Pregnancy | Amyloid beta-Peptides - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - physiology | Signal Transduction - drug effects | RNA, Small Interfering | Index Medicus | Tyrosine | Cell culture | Neuroprotection | Nitration | Phosphorylation | Glucocorticoids | Neurons | Cortex | Estrogen receptors | Extracellular signal-regulated kinase | siRNA | Neuroprotective agents | Nitric-oxide synthase | Nuclear transport | Presenilin 2 | Nitric oxide | ginsenosides | Injuries | Apoptosis
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 2012, Volume 675, Issue 1, pp. 15 - 21
The level of β-site APP-cleaving enzyme 1 (BACE1) has been documented to increase in the brains of patients with Alzheimer's disease, which has resulted in... 
BACE1 | Amyloidgenesis | Ginsenoside | Amyloid precursor protein | PPARγ | SECRETASE | ACTIVATED RECEPTOR-GAMMA | ALZHEIMERS-DISEASE | PPAR gamma | PEPTIDE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY & PHARMACY | PRECURSOR PROTEIN | PROMOTER | EXPRESSION | Amyloid Precursor Protein Secretases - genetics | Nerve Tissue Proteins - secretion | Neurons - pathology | Humans | Amyloid beta-Peptides - secretion | Drugs, Chinese Herbal - pharmacology | Ginsenosides - pharmacology | Protein Transport - drug effects | Aspartic Acid Endopeptidases - genetics | PPAR gamma - metabolism | Promoter Regions, Genetic - drug effects | RNA, Messenger - metabolism | Amyloid beta-Peptides - genetics | Amyloid beta-Peptides - metabolism | Amyloid beta-Protein Precursor - metabolism | Neurons - secretion | Neurons - metabolism | Neurons - drug effects | Peptide Fragments - genetics | Recombinant Proteins - metabolism | Cell Line | Peptide Fragments - metabolism | Aspartic Acid Endopeptidases - antagonists & inhibitors | Recombinant Proteins - secretion | Peptide Fragments - secretion | Alzheimer Disease - drug therapy | Nerve Tissue Proteins - genetics | Gene Expression Regulation - drug effects | Nerve Tissue Proteins - metabolism | Amyloid Precursor Protein Secretases - metabolism | Amyloid beta-Protein Precursor - genetics | Animals | PPAR gamma - antagonists & inhibitors | Peptide Fragments - antagonists & inhibitors | Aspartic Acid Endopeptidases - metabolism | Central Nervous System Agents - pharmacology | PPAR gamma - agonists | Mice | Amyloid Precursor Protein Secretases - antagonists & inhibitors | Amyloid beta-Protein Precursor - antagonists & inhibitors | Brain | Enzymes | Animal models | Transcription factors | Translation | Neurodegenerative diseases | beta -Site APP cleaving enzyme 1 | Memory | Cognitive ability | beta -Amyloid | Regulatory sequences | Nuclear transport | Promoters | pioglitazone | ginsenosides | Peroxisome proliferator-activated receptors | Alzheimer's disease | Cytoplasm | Index Medicus
Journal Article